Generate a tailored SOP for Dr. Baris Borsa. Improve your application with a focused, well-structured draft.
Baris Borsa is a Principal Research Engineer at Linköping University, focusing on developing new targeted therapeutics and diagnostics for infectious diseases using nucleic acid probes. He graduated from Istanbul University Cerrahpasa Medical Faculty in 2004 and gained his Medical Microbiology Specialist degree in 2009 after a four-year residency at Sisli Etfal Training Research Hospital. Borsa began his academic career as an Assistant Professor at Altinbas University in 2013, where he held various administrative roles, including Vice Dean of the Medical Faculty. He continued his career at Yeditepe University, achieving the rank of Associate Professor in 2018. He joined Linköping University as a postdoctoral researcher, working on projects aimed at combating the rise of antimicrobial resistance. His current research includes the development of a first-in-kind targeted oligonucleotide antibiotic aimed at the major human pathogen, Staphylococcus aureus. Borsa's expertise spans bacteriology, antimicrobial resistance, drug discovery, and diagnostics. He has contributed significantly to the field with numerous publications in esteemed journals.
Linköping University • Linköping/Sweden
Conducted research in the Nucleic Acids Technologies Laboratory, focusing on antibiotic development.
Yeditepe University School of Medicine • Istanbul/Turkey
Lectured and researched in medical microbiology.
Altinbas University School of Medicine • Istanbul/Turkey
Responsible for teaching and administrative assignments in the Department of Medical Microbiology.
Requirements are standardized across the Faculty of Science and Engineering (Institute of Technology) for international Master's programs.